18 Oct
|
Alexion, AstraZeneca Rare Disease
|
Mississauga
18 Oct
Alexion, AstraZeneca Rare Disease
Mississauga
Drives patient insights and strategy for rare diseases from drug development to commercialization, collaborating with stakeholders to improve patient access and elevate the patient voice across the healthcare system.
📌 Global Patient Insights & Solution (Gpis), Paths Strategic Partner - $146,108 - $191,766.8 A Year (Mississauga)
🏢 Alexion, AstraZeneca Rare Disease
📍 Mississauga